• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. INTERCEED* XL (TC7); BARRIER, ABSORBABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. INTERCEED* XL (TC7); BARRIER, ABSORBABLE, ADHESION Back to Search Results
Catalog Number 4350XL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Pain (1994)
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.Attempts are being made to obtain the additional information.To date no response has been provided.If further details are received at the later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure product lot number.What is physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status?.
 
Event Description
It was reported that the patient underwent a laparoscopic hepatectomy on (b)(6) 2018 and for the hepatoduodenal mesenterium, the absorbable adhesive barrier was placed between the bottom of the liver and the duodenum of the stomach.The absorbable adhesive barrier was contacted on the gallbladder.The absorbable adhesive barrier was used for lowering the adhesion risk when doing the pringle method in case of a reoperation.Two or three days after the surgery, the patient complained of pain on the right flank in the ward.The pain was like murphy¿s sign.And the patient¿s crp level and liver enzyme level rose.It was reported that cholecystitis occurred.Image diagnosis was not performed.The symptom was relieved by 3 days fasting and antibiotic administration.As of (b)(6), the patient has been discharged from the hospital.The surgeon commented that there was no causal relationship between the device and the event.
 
Manufacturer Narrative
Method codes: 3331.The review of the batch manufacturing records was conducted, and the batch met all finished goods release criteria.Additional information was requested, and the following was obtained: the patient demographic info: age, gender, weight, bmi at the time of index procedure =>no further information is available.Product lot number =>possible lot was mgb6681.What is physician¿s opinion as to the etiology of or contributing factors to this event? =>no further information is available.What is the patient's current status? =>the patient has been discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
BARRIER, ABSORBABLE, ADHESION
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8247835
MDR Text Key133057138
Report Number2210968-2019-78402
Device Sequence Number1
Product Code MCN
UDI-Device Identifier10705031147843
UDI-Public10705031147843
Combination Product (y/n)N
PMA/PMN Number
P880047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2023
Device Catalogue Number4350XL
Device Lot NumberMGB6681
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/18/2018
Initial Date FDA Received01/15/2019
Supplement Dates Manufacturer Received01/16/2019
Supplement Dates FDA Received01/30/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-